Top Page
Ambac Financial
(NYSE:AMBC)
Ambac Financial (AMBC) vs. SPDR S&P 500 ETF (SPY)
Ambac Financial Business Overview & Revenue Model
Ambac Financial Earnings Call Summary
Ambac Financial Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.13M | 235.81M | 124.73M | 53.61M | 247.00M | 156.00M |
| Gross Profit | -16.86M | 98.65M | 47.99M | 24.36M | 319.00M | -69.00M |
| EBITDA | -141.81M | -30.52M | -18.99M | -31.91M | 246.00M | -160.00M |
| Net Income | -780.16M | -556.45M | 3.63M | 521.25M | -17.00M | -437.00M |
Balance Sheet | ||||||
| Total Assets | 2.15B | 8.06B | 8.43B | 7.97B | 12.30B | 13.22B |
| Cash, Cash Equivalents and Short-Term Investments | 478.69M | 331.90M | 354.96M | 1.93B | 1.85B | 2.83B |
| Total Debt | 0.00 | 150.00M | 3.48B | 3.75B | 6.45B | 7.23B |
| Total Liabilities | 1.00B | 6.86B | 7.00B | 6.65B | 11.19B | 12.07B |
| Stockholders Equity | 843.38M | 856.91M | 1.36B | 1.25B | 1.04B | 1.08B |
Cash Flow | ||||||
| Free Cash Flow | -34.95M | 762.00K | 200.00M | 70.37M | -131.00M | -353.00M |
| Operating Cash Flow | -34.95M | 762.00K | 200.00M | 70.37M | -131.00M | -175.00M |
| Investing Cash Flow | 112.78M | -166.37M | 435.00M | -41.16M | 776.00M | 432.00M |
| Financing Cash Flow | -78.88M | 194.22M | -423.00M | -19.23M | -657.00M | -303.00M |
Ambac Financial Technical Analysis
Ambac Financial Risk Analysis
Ambac Financial Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $6.22B | 8.94 | 14.40% | 2.01% | 2.20% | 9.90% | |
73 Outperform | $6.10B | 9.02 | 12.35% | 1.99% | 2.78% | -0.50% | |
73 Outperform | $4.03B | 10.72 | 7.06% | 1.54% | 7.56% | -38.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $4.68B | 8.61 | 12.56% | 2.86% | -3.68% | 3.65% | |
58 Neutral | $395.62M | ― | -4.14% | ― | -37.46% | -117.36% | |
49 Neutral | $342.31M | -1.48 | ― | ― | ― | 67.72% |
Ambac Financial Corporate Events
Ambac Financial Group, Inc. is an insurance holding company that operates in the specialty property and casualty insurance sector, offering a diverse range of insurance underwriting and distribution services in the U.S. and U.K. The company is publicly traded on the New York Stock Exchange under the symbol AMBC.
The recent earnings call for Octave Specialty Group, formerly known as Ambac Financial Group, highlighted a transformative phase for the company. While there were significant achievements in rebranding, capital management, and organic growth initiatives, the financial challenges such as net loss, increased loss ratios, and adjusted EBITDA loss were also evident. This presents a balanced view of strategic progress against ongoing financial hurdles.
On November 10, 2025, Ambac Financial Group, Inc. announced its rebranding to Octave Specialty Group, Inc., marking a significant shift in its strategic focus towards becoming a leading specialty insurance platform. This rebranding follows the sale of its legacy financial guarantee business and reflects its commitment to acquiring and building high-performing managing general agency businesses in the U.S., U.K., and Bermuda. The company will trade under the new ticker symbol ‘NYSE: OSG’ starting November 20, 2025. The rebrand includes a new identity for its divisions, with Cirrata Group becoming Octave Partners and Beat Capital Partners becoming Octave Ventures, while maintaining existing brands for its MGAs and hybrid fronting carrier, Everspan Group. The new brand identity symbolizes Octave’s dedication to innovation, collaboration, and performance, aiming to create long-term shareholder value.
The most recent analyst rating on (AMBC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
On October 31, 2025, Ambac Financial Group completed its acquisition of ArmadaCorp Capital, LLC, a subsidiary of Sirius Acquisitions Holding Company, for approximately $250 million. The acquisition was funded through a combination of a $100 million term loan, $20 million from a revolving credit facility, and cash on hand. This strategic move is expected to strengthen Ambac’s financial profile and diversify its distribution platform, with ArmadaCare continuing to operate as a wholly owned subsidiary under its existing management.
The most recent analyst rating on (AMBC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
On September 30, 2025, Ambac Financial Group, Inc. accelerated the vesting of performance stock unit awards for its top executives following the sale of Ambac Assurance Corporation on September 29, 2025. The acceleration was due to the completion of legacy business activities tied to the sale, resulting in 368,313 PSUs vesting for CEO Claude LeBlanc, 89,071 for CFO David Trick, and 79,441 for COO R. Sharon Smith.
The most recent analyst rating on (AMBC) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
On September 29, 2025, Ambac Financial Group announced its agreement to acquire ArmadaCare, a leading supplemental health insurance program manager, for $250 million from SiriusPoint Ltd. This acquisition is expected to significantly enhance Ambac’s market position, accelerate its growth trajectory, and strengthen its specialty insurance distribution strategy. The transaction is anticipated to close in the fourth quarter of 2025, subject to customary closing conditions. Ambac plans to finance the acquisition through cash on hand and newly issued debt, including a $120 million commitment from Truist Bank. The acquisition is expected to be accretive to Ambac shareholders by 2026, enhancing the company’s financial profile and offering substantial revenue synergy opportunities.
The most recent analyst rating on (AMBC) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
On September 29, 2025, Ambac Financial Group, Inc. entered into new employment agreements with key executives, including Claude LeBlanc, David Trick, and R. Sharon Smith, to continue their roles within the company. These agreements include provisions for base salaries, bonuses, and special awards, with conditions for termination and non-renewal outlined. Additionally, the company announced leadership changes following the resignation of Daniel McGinnis and Stephen M. Ksenak, with R. Sharon Smith and Lawrence F. Metz assuming new roles. The company also appointed Cristina Ahn as Chief Accounting Officer following the sale of Ambac Assurance Corporation.
The most recent analyst rating on (AMBC) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
On September 29, 2025, Ambac Financial Group completed the sale of its legacy financial guarantee businesses, Ambac Assurance Corporation and Ambac Assurance UK Limited, to Oaktree Capital Management for $420 million in cash. This transaction marks a strategic transformation for Ambac, allowing it to focus on becoming a pure-play MGA and specialty insurance platform, which is expected to drive long-term growth and value creation.
The most recent analyst rating on (AMBC) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Ambac Financial stock, see the AMBC Stock Forecast page.
Despite Ambac Financial Group’s robust growth in premiums and revenue, the recent earnings call painted a mixed picture, balancing positive strides with significant financial challenges. The company showcased strong operational performance, yet faced notable financial losses and increased expenses, reflecting a complex financial landscape.